top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Advances in Head and Neck Cancer Immunology and Immunotherapy
Advances in Head and Neck Cancer Immunology and Immunotherapy
Autore Abu-Eid Rasha
Pubbl/distr/stampa Frontiers Media SA, 2019
Descrizione fisica 1 online resource (64 p.)
Soggetto topico Medicine and Nursing
Oncology
Soggetto non controllato cancer immunology
cancer vaccine
head and neck cancer
human leukocyte antigen
Immune check point inhibitor
Immunotharapy
Regulatory T (Treg) cell
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557529703321
Abu-Eid Rasha  
Frontiers Media SA, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Immunogenic Cell Death in Cancer: From Benchside Research to Bedside
Immunogenic Cell Death in Cancer: From Benchside Research to Bedside
Autore Abhishek D. Garg
Pubbl/distr/stampa Frontiers Media SA, 2016
Descrizione fisica 1 online resource (145 p.)
Collana Frontiers Research Topics
Soggetto topico Cell Death
Apoptosis
Monitoring, Immunologic
Genes, Tumor Suppressor
Immunogenic Cell Death
Neoplasms
Soggetto non controllato anti-tumor immunity
Apoptosis
cancer immunology
cancer immunotherapy
Cell Death
DAMPs
danger signals
immunocontexture
immunosurveillance
necroptosis
patient immunology
prognostic/predictive biomarker
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Immunogenic Cell Death in Cancer
Record Nr. UNINA-9910163538103321
Abhishek D. Garg  
Frontiers Media SA, 2016
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Immunophenotyping in Autoimmune Diseases and Cancer
Immunophenotyping in Autoimmune Diseases and Cancer
Autore Szebeni Gábor J
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (170 p.)
Soggetto topico Medicine
Soggetto non controllato accidental cell death
Activating transcription factor 6 (ATF6)
B cells
breast cancer
cancer
cancer immunology
CD180
CD8+CD28− T cells
cell therapy
chimeric antigen receptor
choriocarcinoma
citrate synthase
CpG
dcSSc
DDR
DNA topoisomerase I
flow cytometry
galectin
galectin 1
gestational trophoblastic disease
glioblastoma
Glucose-regulated protein 78 (GRP78)
glycosylation
glycosylation enzymes
hydatidiform mole
IgM
IL-10
IL-6
immune cells
immunohistochemistry
immunophenotyping
immunotherapy
Inositol-requiring enzyme 1 (IRE1)
lectin binding
macrophage
malignant glioma
metastatic breast cancer
myeloid-derived suppressor cells
natural autoantibodies
neuroendocrine carcinoma
neuroendocrine neoplasia
neuroendocrine tumor
non-switched B cells
oncosis
parthanatos
PKR-like endoplasmic reticulum kinase (PERK)
placental-specific gene
RP105
sialylation
single cell mass cytometry
syntaxin 1
systemic lupus erythematosus
systemic sclerosis
systems biology
T cell
T cells
TLR
trastuzumab
trophoblast differentiation
tumor microenvironment
unfolded protein response
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557289203321
Szebeni Gábor J  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Molecular Pathways in Cancers
Molecular Pathways in Cancers
Autore Cristóbal Ion
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (284 p.)
Soggetto topico Medicine and Nursing
Oncology
Soggetto non controllato acetylation
actin cytoskeletal reorganization
adaptive immunity
advanced ovarian cancer
anti-receptor therapy
BET inhibitors
biomarkers
bladder cancer initiation
breast cancer
CALR
cancer
cancer immunology
cancer therapeutics
carcinogenicity
CD99 agonist
complement system
DUSP1
EGFR dimerization
endocytosis
epigenetic
epigenome
epithelial cells
FAK dephosphorylation
genome
glioblastoma
gp120
hepatocellular carcinoma
human immunodeficiency virus type 1
immune checkpoint inhibitors
immune evasion
immunotherapy
innate immunity
JAK2
luminal breast cancer
MAPK
matrix protein p17
metastasis
metastatic melanoma
methylation
migration and invasion
mitochondria
molecular targeted agents
MPL
MS-determined phosphopeptides
mTOR
myeloproliferative neoplasms
n/a
Nef
NIMA-related kinase 1 (NEK1)
non-coding RNA
OMD
oncogenic signaling pathway
ovarian cancer
oxidative stress
OXPHOS
pancreatic ductal adenocarcinoma
partial EMT
patient survival
pBRD4
PI3K
PP2A
PRELP
prognosis
prostate cancer
PTPN12
Rac1
reactive oxygen species
resistance
reverse transcriptase
RhoA
SET
signaling pathways
small-cell lung cancer
Snail
splicing pathway
TAK-228
Tat
thioridazine (THD)
tight junction
tousled-like kinase (TLK)
TPOR
trastuzumab
tripeptide
triple negative breast cancer
triple-negative breast cancer
tumor immune microenvironment
tumor microenvironment
tumor suppression gene
Warburg effect
yes-associated protein 1 (YAP1)
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910566473703321
Cristóbal Ion  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui